US clears Novavax COVID booster dose

FILE - In this image provided by the Serum Institute of India, vials of freshly manufactured Novavax COVID-19 vaccines wait to be labeled in 2022, in Pune, India. On Wednesday, Oct. 19, 2022, U.S. regulators authorized a booster dose of the COVID-19 vaccine made by Novavax. (Serum Institute of India for Novavax via AP)

WASHINGTON (AP) — U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax.

The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the updated omicron-targeting Pfizer or Moderna boosters for medical or accessibility reasons -- or who otherwise would not receive a COVID-19 booster shot at all.

The ºÃÉ«tv Press. All rights reserved.